Resources and Insights

A Successful PAI for a new Peptide Drug from Japan PMDA

Our peptide manufacturing facility at Changzhou site has successfully passed the Pre-Approval Inspection by Japan Pharmaceuticals and Medical Devices Agency...

Expansion Plan Announced during 2024 DCAT Week

WuXi STA is proceeding with a major multi-site, global expansion plan to enhance its manufacturing capabilities and capacities.

2024 CDMO Leadership Awards

Exciting moment! We’ve been honored with the 2024 CDMO Leadership Awards in all six core categories: Capabilities, Compatibility, Expertise, Quality,...

Oligonucleotide Drug Discovery

Oligonucleotide Drug Development (CMC)

Accelerating PPMO Development and Large-scale Manufacturing with Integrated Peptide

Webinar: Challenges and Opportunities in Peptide Drug Conjugates (PDCs)

Middletown Campus Topping Off Ceremony (Delaware, USA)

Middletown Campus Groundbreaking Ceremony (Delaware, USA)